Teriparatide intranasal (Marina Biotech)

N/A

Report date: 2022/03/14 18:05:37

Base Information

Drug NameTeriparatide intranasal (Marina Biotech)
Drug Alias Name鼻用特立帕肽PTH1-34 nasal spray - MDRNA/Procter & GambleParathyroid hormone nasal spray - MDRNA/Procter & Gamble
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionOsteogenesis stimulantsParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMarina Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMarina Biotech
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A